Multiple Ca2؉ release and entry mechanisms and potential cytoskeletal targets have been implicated in vascular endothelial barrier dysfunction; however, the immediate downstream effectors of Ca 2؉ signals in the regulation of endothelial permeability still remain unclear. In the present study, we evaluated the contribution of multifunctional Ca 2؉ /calmodulin-dependent protein kinase II (CaMKII) as a mediator of thrombin-stimulated increases in human umbilical vein endothelial cell (HUVEC) monolayer permeability. For the first time, we identified the CaMKII␦ 6 isoform as the predominant CaMKII isoform expressed in endothelium. As little as 2.5 nM thrombin maximally increased CaMKII␦ 6 activation assessed by Thr 287 autophosphorylation. Electroporation of siRNA targeting endogenous CaMKII␦ (siCaMKII␦) suppressed expression of the kinase by >80% and significantly inhibited 2.5 nM thrombin-induced increases in monolayer permeability assessed by electrical cellsubstrate impedance sensing (ECIS). siCaMKII␦ inhibited 2.5 nM thrombin-induced activation of RhoA, but had no effect on thrombin-induced ERK1/2 activation. Although Rho kinase inhibition strongly suppressed thrombin-induced HUVEC hyperpermeability, inhibiting ERK1/2 activation had no effect. In contrast to previous reports, these results indicate that thrombin-induced ERK1/2 activation in endothelial cells is not mediated by CaMKII and is not involved in endothelial barrier hyperpermeability. Instead, CaMKII␦ 6 mediates thrombin-induced HUVEC barrier dysfunction through RhoA/Rho kinase as downstream intermediates. Moreover, the relative contribution of the CaMKII␦ 6 /RhoA pathway(s) diminished with increasing thrombin stimulation, indicating recruitment of alternative signaling pathways mediating endothelial barrier dysfunction, dependent upon thrombin concentration.Endothelial cells line the luminal surface of blood vessels where they regulate the flux and/or transport of fluid, macromolecules and white blood cells from the vascular space to the interstitium. A loss of barrier function as found with inflammation leads to the accumulation of fluid that can disrupt tissue function. Thrombin, a key pro-coagulant serine-protease, is a well known inflammatory mediator that induces endothelial barrier dysfunction by activating endothelial expressed protease-activated receptors (PARs), resulting in activation of key signaling pathways, including increases in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ), that mediate cytoskeletal reorganization through myosin light chain (MLC)-dependent EC contraction (1) and the disassembly of VE-cadherin containing adherent junctions (2). Multiple Ca 2ϩ release and entry mechanisms may contribute to agonist-dependent increases in [Ca 2ϩ ] i in endothelial cells including Oria1/STIM1-mediated pathways (3) and various TRP channels (4), including TRPC4 plasma membrane channels (5, 6). However, the immediate downstream effectors of Ca 2ϩ signaling pathways in the regulation of EC permeability still remain unclear.A numb...